CNX Therapeutics is a European pharmaceutical company dedicated to improving the lives of patients through the supply of essential medicines.
We commercialise and distribute a portfolio of speciality brands and hospital products in 40 countries worldwide, both directly and through strategic partnerships.
Our vision is to become a recognised partner of choice through our commercial excellence, patient focus and presence across Europe.
We aim to have a positive impact on society through our pioneering focus on our Environment, Social and Governance (ESG) goals.
CNX Therapeutics Secures Debt Facility to Fuel Acquisition Drive
CNX Therapeutics has secured its first debt facility from Credit funds managed by Ares Management, a global alternative investment manager.